Matthew B.K Shaw
Mr Matthew B.K. Shaw is a Consultant Urological Surgeon with specialist interests in kidney stone disease, prostate enlargement and prostate cancer diagnosis. He offers a broad surgical practice, combining clinical care with research, guideline development, patient safety leadership and medical education across Newcastle and the North East.
About Mr Shaw
Mr Shaw qualified from Oriel College, University of Oxford in 1997 before developing an internationally recognised Urology practice in the North East of England. Oxford led to a Surgical Training Scheme in the East Midlands before taking up a prestigious research fellowship at the University of Indiana, the highest rated Paediatric Urology training facility in the USA. His research focussed on the development of the obstructed bladder and led to the award of a Doctorate of Medicine (MD). Mr Shaw trained as a Urology Specialist in the North East of England and was appointed to the Specialist Register for Urology in 2009. He has held the post of Consultant Urological Surgeon at the Freeman Hospital since 2009 where he has been Clinical Lead for Urology in Northumbria and from 2022, Clinical Director for Quality and Patient Safety in Newcastle.
Mr Shaw offers an extensive Surgical practice, performing a wide range of operations from scrotal surgery to complex prostate and renal stone procedures. He has developed an International reputation for the management of renal stone, prostate enlargement & prostate cancer diagnosis and has lectured across the world on these topics. Mr Shaw has worked nationally on the development of clinical guidelines and quality standards in medical practice, including the National Institute for Health and Care Excellence (NICE). He is research active, having published many peer-reviewed research articles, together with invited reviews and clinical book chapters. Currently, Mr Shaw is Principal Investigator for a large National Institute for Health and Care Research (NIHR)-sponsored trial investigating thromboembolic disease in surgical patients. These achievements led to Mr Shaw obtaining a National Clinical Impact Award in 2023 as recognition of clinical, research and managerial excellence.
Mr Shaw’s focus is on delivering high quality care with patient safety at the core of his practice; this resulted in his appointment as Clinical Director for quality and patient safety in Newcastle Hospitals. He has pioneered the use of IT and educational techniques to improve patient safety by enhancing professional standards and performance. He is well recognised through appraisal feedback as being caring and good at listening. Mr Shaw’s surgical outcome information is, of course, subject to national scrutiny.
Mr Shaw has published more than 30 peer-reviewed scientific articles, book chapters and invited articles.
